Table 1.
Individual interviewee demographics.
| Cohort: participant numbera,b,c | Age (years) | Sex | Cancer type classification | Stage of treatment (active therapy or survivorship) |
| 1.1 | 55 | F | Breast | Survivorship |
| 1.2 | 42 | F | Breast | Survivorship |
| 1.3 | 54 | M | Melanoma | Active |
| 1.4 | 75 | F | Colorectal | Survivorship |
| 1.5 | 79 | M | Prostate | Survivorship |
| 1.6 | 59 | F | Hematological | Active |
| 1.7 | 58 | F | Breast | Survivorship |
| 2.1 | 30 | M | Hematological | Active |
| 2.2 | 52 | F | Hematological | Active |
| 2.3 | 60 | F | Breast | Survivorship |
| 2.4 | 61 | F | Breast | Active |
| 2.5 | 57 | M | Head and neck | Survivorship |
| 3.1 | 40 | M | Colorectal | Active |
| 3.2 | 73 | F | Breast | Survivorship |
| 3.3 | 59 | F | Breast | Survivorship |
| 3.4 | 51 | M | Hematological | Survivorship |
| 3.5 | 54 | F | Lung | Survivorship |
aCohort 1: portal/device only.
bCohort 2: additional automated education.
cCohort 3: additional tailored coaching messaging.